共 50 条
- [46] Incidence and risk factors for methotrexate-induced pulmonary disease during treatment of rheumatoid arthritis. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S166 - S166
- [47] Methotrexate-induced pulmonary disease during treatment of rheumatoid arthritis in large clinical trials. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S341 - S341
- [48] Ondansetron therapy prevents from refractory and severe methotrexate-induced nausea in rheumatoid arthritis. ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 971 - 971